Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder

Cancer

Volumn 88, Issue 5, 2000, Pages 1131-1138

  Arima, Jun Ichirou ^a   Imazono, Yoshiharu ^a   Takebayashi, Yuji ^a   Nishiyama, Kenryu ^a   Shirahama, Tsutomu ^a   Akiba, Suminori ^a   Furukawa, Tatsuhiko ^a   Akiyama, Shin Ichi ^a   Ohi, Yoshitada ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Prognostic factor; Thymidine phosphorylase; Transitional cell carcinoma

Indexed keywords

THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER INFILTRATION; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; EPITHELIUM; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SPECTROPHOTOMETRY; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0034163299     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000301)88:5<1131::AID-CNCR25>3.0.CO;2-P     Document Type: Article

References (35)

1. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267: 10931-4.
2. Dickinson A, Fox S, Persad R, Hollyer J, Sibley G, Harris A. Quantitation of angiogenesis is an independent predictor of prognosis in invasive bladder cancer. Br J Urol 1994;74: 762-6.
3. Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995;87:1603-12.
4. Friedkin M, Roberts D. The enzymatic synthesis of nucleosides, an efficient method employing nucleoside phosphorylase. J Biol Chem 1954;207:245-56.
5. Krenitsky TA, Koszalka GW, Tuttle JV. Purine nucleoside synthesis, an efficient method employing nucleoside phosphorylases. Biochemistry 1981;20:3615-21.
6. Iltzsch MH, Kouni MH, Cha S. Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 1985;24: 6799-807.
7. Desgranges C, Razaka G, Rabaud H, Bricaud H. Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase. Biochim Biophys Acta 1981;654:211-8.
8. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S. Angiogenic factor. Nature 1992;356:668.
9. Usuki K, Saras I, Waltenberger J, Miyazono K, Pierce G, Thomason A, et al. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun 1992;184:1311-6.
10. Moghaddam A, Bicknell R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 1992;31:12141-6.
11. Sumizawa T, Furukawa T, Haraguchi M, Yoshimura A, Ishizawa M, Yamada Y, et al. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biochem 1993;114:9-14.
12. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, et al. Angiogenic activity of enzymes [letter]. Nature 1994;368:198.
13. Pauly IL, Schuller MG, Zelcer AA, Kris TA, Gore SS. Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients: brief communication. J Natl Cancer Inst 1997;58:1587-90.
14. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, Akiyama S. Purification and tissue distribution of human thymidine phosphorylase: high expression in lymophocytes, reticulocytes, and tumors. Biochim Biophys Acta 1990;1034: 107-13.
15. Reynolds K, Farzaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, et al. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 1994;86:1234-8.
16. Takebayashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, et al. The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 1996;32:1227-32.
17. Toi M, Hoshina D, Taniguchi T, Yamamoto Y, Ishituka H, Tominaga T. Expression of platelet-derived endothelial cell growth factor/thyimidine phosphorylase in human breast cancer. Int J Cancer 1995;64:79-82.
18. Imazono Y, Takebayashi Y, Nishiyama K, Akiba S, Miyadera K, Yamada Y, et al. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 1997;15:2570-8.
19. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996;88: 1110-7.
20. O'Brien TS, Fox SB, Dickinson AJ, Turley H, Westwood M, Moghaddam A, et al. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 1996; 56:4799-804.
21. Mizutani Y, Okada Y, Yoshida O. Expression of platelet-derived endothelial cell growth factor in bladder carcinoma. Cancer 1997;79:1190-4.
22. The Japanese Urological Association, The Japanese Pathological Society and Japanese Radiological Society. General rule for clinical and pathological studies on renal cell carcinoma [in Japanese]. 2nd edition. Tokyo: Kanehara Press, 1992.
23. Hermanek P, Sobin LH, editors. UICC TNM classification of malignant tumors. 4th edition, 2nd revision. Berlin: Spring-Verlag, 1992.
24. Bradford A. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
25. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanky W, Yamada Y, et al. Role of thymidine phosphorylase activity in angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 1995;55:1687-90.
26. Zar JH. Biostatistical analysis. 3rd edition. New Jersey: Prentice Hall, 1996.
27. Nguyen M, Watanabe H, Budson AE, Richie JP, Folkman J. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer. J Natl Cancer Inst 1993;85:241-2.
28. Chopin DK, Caruelle JP, Colombel M, Palcy S, Ravery V, Caruelle D, et al. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J Urol 1993;150:1126-30.
29. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995;55:510-3.
30. Igarashi M, Dhar DK, Kubota H, Yamamoto A, El AO, Nagasue N. The prognostic significance of microvessel denstiy and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer 1998;82:1225-32.
31. Takebayashi Y, Natsugoe S, Baba M, Akiba S, Furukawa T, Miyadera K, et al. Thymidine phosphorylase in human esophageal squamous cell carcinoma. Cancer 1999;85:282-9.
32. Takao S, Takebayashi Y, Xiangming C, Shinchi H, Natsugoe S, Miyadera K, et al. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Clin Cancer Res 1998;4: 1619-24.
33. Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T, et al. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. Biochem Biophys Res Commun 1998;253:797-803.
34. Miyadera K, Suzuki N, Akiyama S, Fukushima M, Yamada Y. Novel functional nucleoside TAS-102, combined from of F3dThd and its modulator (2): inhibitory effect of TPI on tumor-derived angiogenesis and metastasis. Proc Am Assoc Cancer Res 1998;39:609.
35. Matsushita S, Nitanda T, Furukawa T, Sumizawa T, Tani A, Nishimoto K, et al. The effect of thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res 1999;59:1911-6.